precise diagnosis and treatment study on frailty in elderly population in China

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036399

Enrollment

Unknown

Registered

2020-08-22

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

senile frailty

Interventions

Healthy adult group:no

healthy elderly group:no

aged weak group:no

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Permanent residents of central urban and suburban/rural areas in mainland China: 1. Standard for healthy adults: 18-60 years old; Good health; History of organic diseases of important viscera such as centerless, liver, lung, kidney and brain; No recent history of acute illness; 2. The frailty assessment scale assessed no frailty phenotype and no recent history of acute illness; 3. The frailty assessment scale was assessed as the prophase and the stage of frailty.

Exclusion criteria

Exclusion criteria: 1. Recent active organic lesions of important viscera; 2. Progressive tumor; 3. A clear history of allergies; 4. Patients with severe mental disorders; 5. Unable to carry out physical testing or investigation projects due to physical reasons.

Design outcomes

Primary

Measure	Time frame
Inflammatory cytokines;NAD;telomere length;	—

Countries

China

Contacts

Public ContactZhijun Bao

Huadong Hospital

xinyi8681@sina.com+86 13917136999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026